Radioprotective effects of parthenolide lotion against skin injury caused by radiation (REPAIR-1): protocol for a phase 0, non-randomised, double-blind, interventional pilot study
Williams, C. M. D.; Morel, K. L.; Kumorkiewicz-Jamro, A.; Johnstone, D. P.; Le, H. V.; Sweeney, C. J.; Wardill, H. R.
Show abstract
IntroductionRadiation forms the basis of many successful anti-cancer treatment regimens, killing tumour cells by irreversibly damaging their DNA. Unfortunately, radiation indiscriminately kills healthy cells, causing a range of debilitating and highly impactful side effects. One of the most common side effects is damage and burning of the skin, termed radiation-induced dermatitis (RID), which occurs in up to 95% of people undergoing radiation therapy. Although common, RID cannot be prevented and is inadequately managed with various topical solutions. Parthenolide has emerged as a promising radioprotective agent for the management of RID. The REPAIR-1 study is a phase 0, prospective, non-randomised, double-blind, interventional pilot study which aims to assess the efficacy of topical parthenolide application in limiting severe RID. Methods and analysisThe REPAIR-1 study will be conducted at the Royal Adelaide Hospital, South Australia, Australia. Eligible participants for the REPAIR-1 study include adults diagnosed with locally advanced cancer of the head/neck scheduled to receive definitive, bilateral radiation therapy. Once enrolled, eligible participants will receive application of a 1% parthenolide, or placebo lotion, to opposite sides of the head/neck region before and after daily radiation therapy for the duration of their treatment course (6-7 weeks). The primary outcome of this study is absolute RID severity after 4 weeks of radiation therapy defined by both CTCAE v5.0 criteria and the RISRAS tool. Ethics and disseminationThis protocol has been approved by Central Adelaide Local Health Network Human Research Ethics Committee (2024/HRE00241). All participants will be required to provide written informed consent. Results will be disseminated in peer-reviewed journals, and at scientific conferences. Trial registration numberACTRN12625000456459
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Surgical Resection, Radiotherapy, And Percutaneous Thermal Ablation for Treatment of Stage 1 Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis 93%
- Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial 92%
- Protocol summary and statistical analysis plan for the randomized trial of early detection of clinically significant prostate cancer (ProScreen) 89%
Similar papers in this journal
- Normal Tissue Complication Probability (NTCP) prediction model for osteoradionecrosis of the mandible in head and neck cancer patients following radiotherapy: Large-scale observational cohort 95%
- FLASH Radiotherapy Mitigates Radiation-Induced Lymphopenia and Prevents Immunosuppression via Chk1-STAT3 Axis Modulation in a Preclinical Thoracic Irradiation Model 95%
- Multi-institutional Normal Tissue Complication Probability (NTCP) Prediction Model for Mandibular Osteoradionecrosis: Results from the PREDMORN Study 94%
Similar papers in this journal
- Personalized volume-deescalated elective nodal irradiation in oropharyngeal squamous cell carcinoma (DeEscO): a study protocol 95%
- Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancer 95%
- Detection of Alteration in Carotid Artery Volumetry Using Standard-of-care Computed Tomography Surveillance Scans Following Unilateral Radiation Therapy for Early-stage Tonsillar Squamous Cell Carcinoma Survivors: A Cross-Sectional Internally-Matched Carotid Isodose Analysis 93%
Similar papers in this journal
- Precision association of lymphatic disease spread with radiation-associated toxicity in oropharyngeal squamous carcinomas 94%
- LITE SABR M1: a Phase I Trial of Lattice Stereotactic Body Radiotherapy for Large Tumors 94%
- Evaluation of indirect damage and damage saturation effects in dose-response curves of hypofractionated radiotherapy of early-stage NSCLC and brain metastases 93%
Similar papers in this journal
- Efficacy and Cost of High-Frequency IGRT in Elderly Stage III Non-Small-Cell Lung Cancer Patients 93%
- Predictive factors for the development of peritumoral brain edema after LINAC-based radiation treatment in patients with intracranial meningioma 92%
- Study Protocol: LIAM Mc Trial (Linking In with Advice and supports for Men impacted by Metastatic cancer) 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.